Skip to content
Our Company
The Gift of Sight
Our Innovation
Investors + Media
Open Menu
Our Company
ABOUT US
OUR TEAM
Management Team
Board of Directors
OUR CULTURE
The Gift of Sight
WHY SUPERIOR VISION
OUTCOMES MATTER
Our Innovation
PIPELINE
SCIENCE
CLINICAL TRIALS IN WET AMD
Sozinibercept Phase 3 Program
Sozinibercept Phase 2B Results
CLINICAL TRIALS IN DME
PUBLICATIONS
Scientific Presentations
Expanded Access Policy
Investors & Media
OVERVIEW
STOCK INFORMATION
PRESS RELEASES
EVENTS AND PRESENTATIONS
FILINGS
CORPORATE GOVERNANCE
INVESTOR RESOURCES
NEWS
JOIN US
CONTACT US
Search
SEARCH RESULTS FOR
Opthea Announces Publication in Diabetic Macular Edema
READ MORE
Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference
READ MORE
Opthea’s Wet AMD Program to be Featured at FLORetina 2024
READ MORE
Opthea to Participate in Citi 2024 Global Healthcare Conference
READ MORE
Opthea Appoints Kathy Connell to Board of Directors
READ MORE
Opthea’s Wet AMD Program Featured at Ophthalmology Events
READ MORE
Opthea to Participate in November Investor Conferences
READ MORE
About Us
READ MORE
Our Team
READ MORE
Our Culture
READ MORE
« Prev
1
2
3
Next »